"Designing Growth Strategies is in our DNA"

Antibody Drug Conjugate Therapeutics Market Size, Share and Global Trend By Mechanism of Action (HER2 Antibodies, CD30 Antibodies, Anti-CD33 Antibody, CD22 Antibody), By Disease Indication (Blood cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI101172 | Status : Ongoing

 

KEY MARKET INSIGHTS

Antibody drug conjugate therapeutics are emerging as a potential method for the treatment of cancer. Antibody drug conjugate therapeutics are immunotherapy agents that use the potential cytotoxic molecule combined with the monoclonal antibodies through chemical linkers. This, in turn increases the ability of the drug to target the specific tumor cells. It is due to this advantage that antibody drug conjugate therapeutics have now become a hot area of research and investments.

Apart from commercially available products, there are many pipeline products that are being developed by prominent key players. For example, Asana BioSciences LLC. is developing ASN004, an antibody drug conjugate having the ability to selectively target 5T4 oncofetal antigen, which is expressed in malignant tumors. Also, many other pipeline products and strategic collaborations in this field will help the antibody drug conjugate therapeutics market to flourish at a global level.

To gain extensive insights into the market, Request for Customization


The strive to develop novel treatment and drugs for chronic disease such as cancer through increased R&D investment is a major factor driving the growth in global antibody drug conjugate therapeutics market. Also, the potential pipeline products and favorable health reimbursement are the factors that are estimated to fuel the global antibody drug conjugate therapeutics market during the forecast years. 

However, the high production cost associated with antibody drug conjugate and side effect from the drugs is the major factor that can hamper the growth in global antibody drug conjugate therapeutics market.

Key Players Covered


Some of the key players present in the global antibody drug conjugate therapeutics market are Pfizer Inc., Genentech, Seattle Genetics Inc., Synthon Holding B.V., ImmunoGen Inc., AbbVie Inc., Genentech, Inc., Bayer AG, F. Hoffmann-La Roche Ltd, and other players.

SEGMENTATION


























SEGMENTATION


 DETAILS

By Mechanism of Action

· HER2 Antibodies

· CD30 Antibodies

· Anti-CD33 Antibody

· CD22 Antibody

By Disease Indication

· Blood cancer

· Breast Cancer

· Ovarian Cancer

· Lung Cancer

· Brain Tumor

· Others

By Distribution Channel

· Hospital Pharmacy

· Retail Pharmacy

· Online Pharmacy

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Among the segmentation of the global antibody drug conjugate therapeutics market, breast cancer accounted for the largest revenue owing to the prevalence of breast cancer cases, thus boosting the R&D in the development of drugs in the treatment of breast cancer.

Key Insights



  • Mechanism of action for key products

  • Patent analysis

  • Pipeline analysis

  • Advancement in antibody drug conjugate

  • Key mergers and acquisitions


Regional Analysis


Geographically the global antibody drug conjugate therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The antibody drug conjugate therapeutics market is anticipated to expand in North America during the forecast years owing to the favorable health reimbursement and increasing funding for research in antibody drug conjugate therapeutics. In Europe and Asia Pacific, the antibody drug conjugate therapeutics market is projected to expand by the end of 2025 owing to new product launch and increasing trend of strategic collaborations.

Key Industry Developments



  • In March 2019, AstraZeneca entered into collaboration agreement with Daiichi Sankyo Company, Limited, for trastuzumab deruxtecan (DS-8201), an antibody-drug conjugate (ADC) and potential new targeted medicine for cancer treatment.
  • In December 2018, Seattle Genetics Inc. received FDA approval for Adcetris for the treatment of lymphoma.




Key Questions Answer REQUEST SAMPLE
Why to Choose Fortune Business Insights SPEAK TO ANALYST
Antibody Drug Conjugate Therapeutics Market Report
  • Ongoing
  • 2023
  • 2019-2022
  • Pre Book
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
abbvie
Galemed
Amgen
Ansell
Siemens Healthineers
Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X